SOD1 and pulmonary arterial hypertension: The results demonstrated that arctigenin treatment significantly decreased MDA levels and elevated SOD activity, halted the progression of MCT-induced pulmonary arterial hypertension in rats by blocking oxidative stress and lipid peroxidation.